Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 599

1.

The first 3500 years of aspirin history from its roots - A concise summary.

Montinari MR, Minelli S, De Caterina R.

Vascul Pharmacol. 2018 Nov 1. pii: S1537-1891(18)30354-9. doi: 10.1016/j.vph.2018.10.008. [Epub ahead of print] Review.

PMID:
30391545
2.

Non-Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves.

Aimo A, Giugliano RP, De Caterina R.

Circulation. 2018 Sep 25;138(13):1356-1365. doi: 10.1161/CIRCULATIONAHA.118.035612.

PMID:
30354416
3.

[Fourth universal definition of myocardial infarction (2018)].

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL Jr, Apple FS, Alonso Garcia MA, Underwood SR, Canty JM Jr, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS, Newby LK, Virmani R, Vranckx P, Cutlip D, Gibbons RJ, Smith SC, Atar D, Luepker RV, Robertson RM, Bonow RO, Steg PG, O'Gara PT, Fox KAA.

Kardiol Pol. 2018;76(10):1383-1415. doi: 10.5603/KP.2018.0203. Polish. No abstract available.

4.

Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin.

Kotecha D, Pollack CV Jr, De Caterina R, Renda G, Kirchhof P.

J Am Coll Cardiol. 2018 Oct 16;72(16):1984-1986. doi: 10.1016/j.jacc.2018.07.083. No abstract available.

PMID:
30309478
5.

Low-Thrombogenicity Mechanical Heart Valves: Which Antithrombotic Strategy?

Aimo A, Emdin M, De Caterina R.

J Am Coll Cardiol. 2018 Oct 9;72(15):1878-1879. doi: 10.1016/j.jacc.2018.07.065. No abstract available.

PMID:
30286935
6.

Marine n-3 Fatty Acids and Vascular Disease: Solid Evidence in a Sea of Uncertainties.

De Caterina R, Madonna R.

J Am Coll Cardiol. 2018 Oct 2;72(14):1585-1588. doi: 10.1016/j.jacc.2018.07.044. No abstract available.

PMID:
30261958
7.

Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs.

Patti G, Cavallari I, Andreotti F, Calabrò P, Cirillo P, Denas G, Galli M, Golia E, Maddaloni E, Marcucci R, Parato VM, Pengo V, Prisco D, Ricottini E, Renda G, Santilli F, Simeone P, De Caterina R; Working Group on Thrombosis of the Italian Society of Cardiology.

Nat Rev Cardiol. 2018 Sep 24. doi: 10.1038/s41569-018-0080-2. [Epub ahead of print] Review.

PMID:
30250166
8.

Prognostic Role of Cardiac Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy.

Aquaro GD, Pingitore A, Di Bella G, Piaggi P, Gaeta R, Grigoratos C, Altinier A, Pantano A, Strata E, De Caterina R, Sinagra G, Emdin M.

Am J Cardiol. 2018 Aug 21. pii: S0002-9149(18)31637-0. doi: 10.1016/j.amjcard.2018.08.007. [Epub ahead of print]

PMID:
30220419
9.

Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.

Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, Siller-Matula J, Schnabel RB, Cemin R, Kirchhof P, De Caterina R.

Int J Cardiol. 2018 Nov 1;270:160-166. doi: 10.1016/j.ijcard.2018.06.098. Epub 2018 Jun 28.

PMID:
30220376
10.

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.

Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M, Huber K, Hylek EM, Lopes RD, Oh BH, Siegbahn A.

Heart. 2018 Sep 12. pii: heartjnl-2018-313351. doi: 10.1136/heartjnl-2018-313351. [Epub ahead of print]

11.

Fourth universal definition of myocardial infarction (2018).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; ESC Scientific Document Group .

Eur Heart J. 2018 Aug 25. doi: 10.1093/eurheartj/ehy462. [Epub ahead of print] No abstract available.

PMID:
30165617
12.

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.

Valgimigli M, Frigoli E, Leonardi S, Vranckx P, Rothenbühler M, Tebaldi M, Varbella F, Calabrò P, Garducci S, Rubartelli P, Briguori C, Andó G, Ferrario M, Limbruno U, Garbo R, Sganzerla P, Russo F, Nazzaro M, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Ferrante G, Santarelli A, Sardella G, de Cesare N, Tosi P, van 't Hof A, Omerovic E, Brugaletta S, Windecker S, Heg D, Jüni P; MATRIX Investigators.

Lancet. 2018 Sep 8;392(10150):835-848. doi: 10.1016/S0140-6736(18)31714-8. Epub 2018 Aug 25.

PMID:
30153988
13.

Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis.

Ricci F, Sutton R, Palermi S, Tana C, Renda G, Gallina S, Melander O, De Caterina R, Fedorowski A.

J Cardiovasc Electrophysiol. 2018 Aug 14. doi: 10.1111/jce.13715. [Epub ahead of print]

PMID:
30106212
14.

Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.

Horowitz JD, De Caterina R, Heresztyn T, Alexander JH, Andersson U, Lopes RD, Steg PG, Hylek EM, Mohan P, Hanna M, Jansky P, Granger CB, Wallentin L; ARISTOTLE Investigators.

J Am Coll Cardiol. 2018 Aug 14;72(7):721-733. doi: 10.1016/j.jacc.2018.05.058.

PMID:
30092948
15.

Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation.

Renda G, De Caterina R.

J Am Coll Cardiol. 2018 Jul 17;72(3):283-286. doi: 10.1016/j.jacc.2018.05.015. Epub 2018 Jul 9. No abstract available.

PMID:
30012321
16.

Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study.

Poli D, Antonucci E, Pengo V, Migliaccio L, Testa S, Lodigiani C, Coffetti N, Facchinetti R, Serricchio G, Falco P, Mangione C, Masottini S, Ruocco L, De Caterina R, Palareti G; Italian Federation of Anticoagulation Clinics.

Int J Cardiol. 2018 Sep 15;267:68-73. doi: 10.1016/j.ijcard.2018.04.042.

PMID:
29957264
17.

Cell based mechanosensing in vascular patho-biology: More than a simple go-with the flow.

Garoffolo G, Madonna R, de Caterina R, Pesce M.

Vascul Pharmacol. 2018 Jun 19. pii: S1537-1891(17)30463-9. doi: 10.1016/j.vph.2018.06.013. [Epub ahead of print] Review. No abstract available.

PMID:
29929011
18.

The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly.

Patti G, Cavallari I, Hanon O, De Caterina R.

Int J Cardiol. 2018 Aug 15;265:118-124. doi: 10.1016/j.ijcard.2018.02.066.

PMID:
29885678
19.

Aspirin and Prognosis in Heart Failure: A Question of Power.

Aimo A, Ripoli A, De Caterina R, Emdin M.

JACC Heart Fail. 2018 Jun;6(6):538-539. doi: 10.1016/j.jchf.2018.02.009. No abstract available.

PMID:
29852936
20.

Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe.

Schnabel RB, Pecen L, Rzayeva N, Lucerna M, Purmah Y, Ojeda FM, De Caterina R, Kirchhof P.

J Am Heart Assoc. 2018 May 18;7(11). pii: e007559. doi: 10.1161/JAHA.117.007559.

21.

Grading of aortic stenosis severity: a head-to-head comparison between cardiac magnetic resonance imaging and echocardiography.

Mantini C, Di Giammarco G, Pizzicannella J, Gallina S, Ricci F, D'Ugo E, Marchetti M, Cotroneo AR, Ahmed N, Bucciarelli-Ducci C, Tartaro A, De Caterina R.

Radiol Med. 2018 Sep;123(9):643-654. doi: 10.1007/s11547-018-0895-2. Epub 2018 May 5.

PMID:
29730841
22.

Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.

Siller-Matula JM, Pecen L, Patti G, Lucerna M, Kirchhof P, Lesiak M, Huber K, Verheugt FWA, Lang IM, Renda G, Schnabel RB, Wachter R, Kotecha D, Sellal JM, Rohla M, Ricci F, De Caterina R; TEAM in AF group.

Int J Cardiol. 2018 Aug 15;265:141-147. doi: 10.1016/j.ijcard.2018.04.093. Epub 2018 Apr 22.

PMID:
29706429
23.

Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis.

Radico F, Zimarino M, Fulgenzi F, Ricci F, Di Nicola M, Jespersen L, Chang SM, Humphries KH, Marzilli M, De Caterina R.

Eur Heart J. 2018 Jun 14;39(23):2135-2146. doi: 10.1093/eurheartj/ehy185.

PMID:
29688324
24.

Innate and adaptive immunity in atherosclerosis.

Miteva K, Madonna R, De Caterina R, Van Linthout S.

Vascul Pharmacol. 2018 Apr 22. pii: S1537-1891(17)30464-0. doi: 10.1016/j.vph.2018.04.006. [Epub ahead of print] Review.

PMID:
29684642
25.

Scoring atherosclerosis in the search of evidence-based personalized medicine.

Ricci F, De Caterina R, Zimarino M.

Int J Cardiol. 2018 Jun 15;261:30-31. doi: 10.1016/j.ijcard.2018.03.038. No abstract available.

PMID:
29657051
26.

State of play and future direction with NOACs: An expert consensus.

Cohen AT, Lip GY, De Caterina R, Heidbuchel H, Zamorano JL, Agnelli G, Verheugt F, Camm AJ.

Vascul Pharmacol. 2018 Jul;106:9-21. doi: 10.1016/j.vph.2018.04.001. Epub 2018 Apr 12. Review.

PMID:
29656119
27.

Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes.

B Schnabel R, Pecen L, Engler D, Lucerna M, Sellal JM, Ojeda FM, De Caterina R, Kirchhof P.

Heart. 2018 Oct;104(19):1608-1614. doi: 10.1136/heartjnl-2017-312569. Epub 2018 Mar 17.

PMID:
29550771
28.

Coronary computed tomography angiography, ECG stress test and nuclear imaging as sources of false-positive results in the detection of coronary artery disease.

Zimarino M, Marano R, Radico F, Curione D, De Caterina R.

J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e133-e138. doi: 10.2459/JCM.0000000000000591. No abstract available.

PMID:
29538163
29.

Oral anticoagulants for atrial fibrillation and acute coronary syndrome with or without stenting.

Muscente F, Tautermann G, De Caterina R.

J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e40-e45. doi: 10.2459/JCM.0000000000000597. No abstract available.

PMID:
29538143
30.

Digoxin and Mortality in Patients With Atrial Fibrillation.

Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L; ARISTOTLE Committees and Investigators.

J Am Coll Cardiol. 2018 Mar 13;71(10):1063-1074. doi: 10.1016/j.jacc.2017.12.060.

PMID:
29519345
31.

[Diagnosis and treatment of blood volume changes in acute heart failure - a brief practical guide].

Ciancetta P, M Maggiore S, Petrini F, De Caterina R.

G Ital Cardiol (Rome). 2018 Jan;19(1):44-53. doi: 10.1714/2852.28778. Italian.

PMID:
29451509
32.

Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage.

Madonna R, Pieragostino D, Balistreri CR, Rossi C, Geng YJ, Del Boccio P, De Caterina R.

Vascul Pharmacol. 2018 Feb 6. pii: S1537-1891(17)30322-1. doi: 10.1016/j.vph.2018.01.009. [Epub ahead of print] Review.

PMID:
29425894
33.

Percutaneous coronary interventions for non-ST elevation acute coronary syndromes - The two faces of inappropriateness.

De Caterina R, Marzilli M.

Int J Cardiol. 2018 Mar 15;255:20-21. doi: 10.1016/j.ijcard.2018.01.016. No abstract available.

PMID:
29425559
34.

Proceedings of the 11th Congress of the International Society of Nutrigenetics and Nutrigenomics (ISNN 2017).

Barrington WT, Salvador AC, Hartiala JA, De Caterina R, Kohlmeier M, Martinez JA, Kreutzer CB, Heber D, Lusis AJ, Li Z, Allayee H.

J Nutrigenet Nutrigenomics. 2017;10(5-6):155-162. doi: 10.1159/000485799. Epub 2018 Jan 17.

35.

Endothelial permeability, LDL deposition, and cardiovascular risk factors-a review.

Mundi S, Massaro M, Scoditti E, Carluccio MA, van Hinsbergh VWM, Iruela-Arispe ML, De Caterina R.

Cardiovasc Res. 2018 Jan 1;114(1):35-52. doi: 10.1093/cvr/cvx226.

PMID:
29228169
37.

Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).

Lip GYH, Merino JL, Dan GA, Themistoclakis S, Ellenbogen KA, De Caterina R, Goudev A, Jin J, Melino M, Winters SM, Goette A.

Am J Cardiol. 2018 Jan 15;121(2):193-198. doi: 10.1016/j.amjcard.2017.10.008. Epub 2017 Nov 20.

38.

Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study.

Ricci F, Barison A, Todiere G, Mantini C, Cotroneo AR, Emdin M, De Caterina R, Galllina S, Aquaro GD.

Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):896-904. doi: 10.1093/ehjci/jex214.

PMID:
29045598
39.

Aspirin and the prevention of a common disease: Colorectal cancer.

Andreotti F, De Caterina R, Crea F.

Int J Cardiol. 2017 Dec 1;248:394-395. doi: 10.1016/j.ijcard.2017.08.013. No abstract available.

PMID:
28942879
40.

Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.

De Caterina R, Brüggenjürgen B, Darius H, Köhler S, Lucerna M, Pecen L, Renda G, Schilling RJ, Schliephacke T, Zamorano JL, Le Heuzey JY, Kirchhof P.

Arch Cardiovasc Dis. 2018 Feb;111(2):74-84. doi: 10.1016/j.acvd.2017.04.007. Epub 2017 Sep 21.

PMID:
28942115
41.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group.

N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

42.

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators.

N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.

43.
44.

Interindividual Variability in Biomarkers of Cardiometabolic Health after Consumption of Major Plant-Food Bioactive Compounds and the Determinants Involved.

Milenkovic D, Morand C, Cassidy A, Konic-Ristic A, Tomás-Barberán F, Ordovas JM, Kroon P, De Caterina R, Rodriguez-Mateos A.

Adv Nutr. 2017 Jul 14;8(4):558-570. doi: 10.3945/an.116.013623. Print 2017 Jul. Review.

45.

Guide for Current Nutrigenetic, Nutrigenomic, and Nutriepigenetic Approaches for Precision Nutrition Involving the Prevention and Management of Chronic Diseases Associated with Obesity.

Ramos-Lopez O, Milagro FI, Allayee H, Chmurzynska A, Choi MS, Curi R, De Caterina R, Ferguson LR, Goni L, Kang JX, Kohlmeier M, Marti A, Moreno LA, Pérusse L, Prasad C, Qi L, Reifen R, Riezu-Boj JI, San-Cristobal R, Santos JL, Martínez JA.

J Nutrigenet Nutrigenomics. 2017;10(1-2):43-62. doi: 10.1159/000477729. Epub 2017 Jul 8.

46.

Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study.

Briguori C, Quintavalle C, D'Alessio F, Donahue M, Roscigno G, De Micco F, Focaccio A, Visconti G, Del Vecchio L, Madonna R, De Caterina R, Condorelli G.

Int J Cardiol. 2017 Oct 1;244:112-118. doi: 10.1016/j.ijcard.2017.06.087. Epub 2017 Jun 27.

PMID:
28668399
47.

Stroke prevention in atrial fibrillation: Past, present and future. Comparing the guidelines and practical decision-making.

Lip G, Freedman B, De Caterina R, Potpara TS.

Thromb Haemost. 2017 Jun 28;117(7):1230-1239. doi: 10.1160/TH16-11-0876. Epub 2017 Jun 9. Review.

PMID:
28597905
48.

Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk.

Volpe M, Battistoni A, Gallo G, Coluccia R, De Caterina R.

High Blood Press Cardiovasc Prev. 2017 Sep;24(3):331-339. doi: 10.1007/s40292-017-0213-4. Epub 2017 Jun 1. Review.

PMID:
28573479
49.

Aspirin in heart failure: don't throw the baby (aspirin) out with the bathwater.

De Caterina R.

Eur J Heart Fail. 2017 Sep;19(9):1089-1094. doi: 10.1002/ejhf.894. Epub 2017 May 31. Review. No abstract available.

50.

[Cardiac tumors: role of magnetic resonance imaging].

Bianco F, Bucciarelli V, Todiere G, Barison A, Festa P, Ait-Ali L, Gallina S, De Caterina R, Aquaro GD.

G Ital Cardiol (Rome). 2017 Apr;18(4):286-294. doi: 10.1714/2683.27471. Review. Italian.

PMID:
28492568

Supplemental Content

Loading ...
Support Center